Aurora Cannabis Inc. (ACB.TO)
| Previous close | 8.03 |
| Open | 8.04 |
| Bid | 8.16 x 0 |
| Ask | 8.17 x 0 |
| Day's range | 8.02 - 8.25 |
| 52-week range | 3.84 - 15.50 |
| Volume | |
| Avg. volume | 1,203,892 |
| Market cap | 445.663M |
| Beta (5Y monthly) | 2.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.28 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.09 |
PR NewswireAurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). Aurora's license grants the company continued domestic cultivation, which has been underway for two years now. Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offe
PR NewswireAurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the "Circular") for the upcoming annual general and special meeting of shareholders (the "Meeting") is now available on the Company's website at www.auroramj.com/investors/corporate-governance as well as under its profile on SEDAR+ (www.sedarplus.ca).
Simply Wall St.Aurora Cannabis Full Year 2024 Earnings: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)
Aurora Cannabis ( TSE:ACB ) Full Year 2024 Results Key Financial Results Revenue: CA$270.3m (up 16% from FY 2023). Net...
